AstraZeneca Claims Study Confirms 100% protection against Severe Disease, Hospitalization and Death in the Primary Analysis of Phase III Trials
Alfredo Cuadros Pharmaceutical AstraZeneca releasing new details in its ongoing COVID-19 vaccine phase 3 trials. The company is claiming to have confirmed 100 percent protection against COVID related severe disease, hospitalization, and death based on primarily analysis. The company bases the statement from…